The patient’s relatively young age, additional findings throughout the clinical workup of other masses at different sites, and the loss of SDHB immunohistochemistry in the UBPGL raised the potential for a germline syndrome, which was then excluded with germline and tumor genetic testing. Here, SDHB is linked to neoplasm.